Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Cytori Therapeutics
3121
Cytori Therapeutics
Health Care
Medical
Technology
Biotechnology
Developing cell therapies for significant medical conditions including hand scleroderma, knee osteoarthritis, thermal burns and stress urinary incontinence.
Suggest edits
Founded
1996
Raised
$67.6M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
Industry
GoFundMe
Dan
Illumina
Edge
San Diego Comic-Con
Software Company
ViaSat Inc.
Companies in the same industry
Aalto University School of Science and Technology
Atlas Biomed
Morphogen-IX
Hepatx
LabRoots
Medicortex Finland Oy
Berry Genomics Co., Ltd.
Alimera Sciences
HiberGene Diagnostics
Centauri Therapeutics Limited
Alexa global traffic share
Twitter followers
Overview
Funding
4
Acquisitions
1
Add info
Add round
16 Jun
2016
$17,100,000
Post-IPO equity
Cytori Closes Rights Offering for Gross Proceeds of $17.1 Million | Business Wire
businesswire
+1
08 Oct
2014
$13,500,000
Post-IPO equity
30 May
2014
$10,000,000
Post-IPO equity
01 Jul
2013
$27,000,000
Debt financing
Silicon Valley Bank
,
GE Capital
,
Oxford Finance
